2006
DOI: 10.1016/j.ajog.2006.03.011
|View full text |Cite
|
Sign up to set email alerts
|

Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
28
0
1

Year Published

2007
2007
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(32 citation statements)
references
References 14 publications
3
28
0
1
Order By: Relevance
“…Besides, the relationship between obstetric complications and elevated hCG levels was not confirmed in two other studies (10,24). In another study, preterm delivery, preeclampsia and large for gestational age were found to be associated with only hCG levels of 3 MoM and the authors concluded that increased fetal surveillance is not warranted with lower values (25). Consistent with our results, a low uE3 level was suggested as an independent risk factor for adverse pregnancy outcome and is particularly associated with preeclampsia, in conjunction with IUGR, SGA, oligohydramnios, preterm delivery and stillbirth (9,12,26).…”
Section: Discussionmentioning
confidence: 78%
“…Besides, the relationship between obstetric complications and elevated hCG levels was not confirmed in two other studies (10,24). In another study, preterm delivery, preeclampsia and large for gestational age were found to be associated with only hCG levels of 3 MoM and the authors concluded that increased fetal surveillance is not warranted with lower values (25). Consistent with our results, a low uE3 level was suggested as an independent risk factor for adverse pregnancy outcome and is particularly associated with preeclampsia, in conjunction with IUGR, SGA, oligohydramnios, preterm delivery and stillbirth (9,12,26).…”
Section: Discussionmentioning
confidence: 78%
“…** Subfertility and its treatment (especially the use of donor eggs, sperm and/or gametes), after correction for multiple gestations. *** Decreased first trimester PAPP-A (pregnancy-associated plasma protein A) 65th centile [141], decreased first or second trimester PlGF (placental growth factor) [154][155][156], unexplained increased second trimester AFP (alphafetoprotein) [142][143][144][145][146][147], increased second trimester hCG [145][146][147][148], increased first or second trimester inhibin A [144,[149][150][151][152], increased second trimester activin. [153].…”
Section: Preventing Preeclampsia and Its Complicationsmentioning
confidence: 99%
“…Raised levels of HCG [50], NGAL [51], TNF-R1 [52], complement activation product B [53], triglycerides [54], low levels of SP-1 [17], human placental lactogen [23], SL-selectin [55], ApoB [56], PAPP-A [39], TGF-β1 [57], PAI-2 [40] and IGFBP-1 [58] have been correlated to subsequent development of preeclampsia, but lack of, or conflicting test performance data, negates their use. Endothelin-1 ↑ 96.8 51 ND [28] P-selectin ↑ 80 91 ND [29] PAPP-A ↓ 11-23 ND ND [30] NGAL ↑ ND ND 0.75 [31] S-Eng ↑ 63 57 ND [32] Inhibin A ↑ 16-35 ND ND [33] Activin A ↑ 20 ND 0.59 [33,34] MMP-9 ↑ ND ND 0.61 [35] Combinations PlGF + PP13 NA 54 ND ND [36] PP13 + UA Doppler NA 90 90 ND [37] UA …”
Section: Second Trimester Biomarkersmentioning
confidence: 99%